From July 1, 2021 to September 30, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 590,751 shares, representing 4.15% for $30 million under the buyback announced on May 2, 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.59 USD | +4.15% | +6.53% | +21.76% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.76% | 388M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.49% | 31.47B | |
+54.44% | 25.24B | |
-13.13% | 15.82B | |
-9.12% | 11.96B | |
-15.45% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on May 2, 2019.